chr14-75048422-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001040108.2(MLH3):​c.1234A>G​(p.Lys412Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000695 in 1,608,284 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00071 ( 1 hom. )

Consequence

MLH3
NM_001040108.2 missense

Scores

9
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 3.26
Variant links:
Genes affected
MLH3 (HGNC:7128): (mutL homolog 3) This gene is a member of the MutL-homolog (MLH) family of DNA mismatch repair (MMR) genes. MLH genes are implicated in maintaining genomic integrity during DNA replication and after meiotic recombination. The protein encoded by this gene functions as a heterodimer with other family members. Somatic mutations in this gene frequently occur in tumors exhibiting microsatellite instability, and germline mutations have been linked to hereditary nonpolyposis colorectal cancer type 7 (HNPCC7). Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017148107).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000578 (88/152342) while in subpopulation NFE AF = 0.000603 (41/68022). AF 95% confidence interval is 0.000457. There are 0 homozygotes in GnomAd4. There are 54 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 88 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MLH3NM_001040108.2 linkc.1234A>G p.Lys412Glu missense_variant Exon 2 of 13 ENST00000355774.7 NP_001035197.1 Q9UHC1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLH3ENST00000355774.7 linkc.1234A>G p.Lys412Glu missense_variant Exon 2 of 13 5 NM_001040108.2 ENSP00000348020.2 Q9UHC1-1
MLH3ENST00000380968.6 linkc.1234A>G p.Lys412Glu missense_variant Exon 2 of 12 1 ENSP00000370355.3 Q9UHC1-2
MLH3ENST00000556257.5 linkc.1234A>G p.Lys412Glu missense_variant Exon 2 of 7 5 ENSP00000451540.1 G3V419

Frequencies

GnomAD3 genomes
AF:
0.000578
AC:
88
AN:
152224
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00367
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000448
AC:
110
AN:
245414
AF XY:
0.000452
show subpopulations
Gnomad AFR exome
AF:
0.0000623
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00260
Gnomad NFE exome
AF:
0.000456
Gnomad OTH exome
AF:
0.000334
GnomAD4 exome
AF:
0.000707
AC:
1029
AN:
1455942
Hom.:
1
Cov.:
35
AF XY:
0.000684
AC XY:
495
AN XY:
723890
show subpopulations
Gnomad4 AFR exome
AF:
0.0000303
AC:
1
AN:
33002
Gnomad4 AMR exome
AF:
0.0000230
AC:
1
AN:
43486
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
25938
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39658
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
84576
Gnomad4 FIN exome
AF:
0.00253
AC:
135
AN:
53312
Gnomad4 NFE exome
AF:
0.000775
AC:
860
AN:
1110078
Gnomad4 Remaining exome
AF:
0.000532
AC:
32
AN:
60144
Heterozygous variant carriers
0
59
118
177
236
295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000578
AC:
88
AN:
152342
Hom.:
0
Cov.:
33
AF XY:
0.000725
AC XY:
54
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.000120
AC:
0.000120221
AN:
0.000120221
Gnomad4 AMR
AF:
0.000131
AC:
0.000130685
AN:
0.000130685
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00367
AC:
0.00367162
AN:
0.00367162
Gnomad4 NFE
AF:
0.000603
AC:
0.000602746
AN:
0.000602746
Gnomad4 OTH
AF:
0.000473
AC:
0.000473037
AN:
0.000473037
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000374
Hom.:
0
Bravo
AF:
0.000295
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000469
AC:
57
EpiCase
AF:
0.000436
EpiControl
AF:
0.000652

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 30, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Uncertain:1
Jun 04, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Colorectal cancer, hereditary nonpolyposis, type 7 Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MLH3-related disorder Benign:1
Dec 23, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T;.;.;T
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D;D;D;.
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.017
T;T;T;T
MetaSVM
Uncertain
0.33
D
MutationAssessor
Benign
1.6
L;L;.;L
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.6
N;.;N;N
REVEL
Uncertain
0.50
Sift
Uncertain
0.0070
D;.;D;D
Sift4G
Benign
0.076
T;T;T;T
Polyphen
1.0
D;D;.;D
Vest4
0.35
MVP
0.92
MPC
0.25
ClinPred
0.054
T
GERP RS
5.7
Varity_R
0.22
gMVP
0.40
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61754769; hg19: chr14-75515125; COSMIC: COSV104587319; API